XML 99 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
Operating Income - Additional Information (Details)
€ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2021
EUR (€)
Jun. 30, 2022
EUR (€)
Jun. 30, 2021
EUR (€)
Dec. 31, 2021
EUR (€)
bond
Disclosure Of Other Income [Line Items]        
Total operating income   € 12,188 € 3,428  
Industrial income recognized   8,790 11  
Revenue   12,188 3,428  
Research tax credit (CIR)   3,398 3,417  
Research tax credit € 5,282 € 8,625   € 5,282
Genfit | Ipsen        
Disclosure Of Other Income [Line Items]        
Proportion of ownership interest in associate (as a percent)   8.00%   8.00%
CIR tax credit        
Disclosure Of Other Income [Line Items]        
Research tax credit (CIR)   € 3,343 € 3,244  
Ipsen        
Disclosure Of Other Income [Line Items]        
Licence fee income 80,000      
Deferred income € 40,000 € 31,834   € 40,000
Sale price, clinical trial phase       € 40,000
Ipsen | Performance obligations satisfied over time        
Disclosure Of Other Income [Line Items]        
Number of Performance Obligations | bond       4